Delivery Order SPE2DB20D2104-SPE2DB24FU40R
Award Date
5/29/24
Potential Completion Date
5/30/24
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. The contract is a Firm Fixed Price Delivery Order valued at $32,824.44, with a completion date of June 28, 2024. The awarding agency is the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RINVOQ ER 15 MG TABLET in the amount of $29,639.62. The award was made by the Defense Logistics Agency (DLA), a defense agency, on November 17, 2022, with a completion date of November 18, 2022. The contract is a Delivery Order under a Firm Fixed Price pricing type. There is no set-aside designation indicated for this award. Amerisourcebergen holds a significant $999,999,999...
This federal contract award for $3,007.71 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier. The contract is for the delivery of RINVOQ ER 15 MG TABLET products, with a completion date of July 25, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp's Corporate Office Division holds significant Indefinite Delivery Contracts...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The award has a ceiling value of $6,783.51 and is a delivery order contract with a firm fixed price. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. The ultimate completion date for the contract is August 23, 2024. Amerisourcebergen Drug Corp is a major...
This federal contract award, valued at $7,296.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. This is a Delivery Order contract with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award, valued at $5,633.37, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, and has an ultimate completion date of February 26, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
This federal contract award is to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, for the delivery of RINVOQ ER 15 MG TABLET UU 30S to the Department of Defense's Medical Supply Chain program. The $65,744.85 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) on September 11, 2024, with a completion date of September 12, 2024. The contract is not set aside for any specific business type. As a key supplier of...
This federal contract award, valued at $30,151.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product, with a completion date of January 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award does not have a set-aside designation, indicating it was an open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the supply of the prescription drug RINVOQ ER 15 MG TABLET to the U.S. government. The contract, valued at $9,742.98, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award IDC, valued up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to...
This federal contract award, valued at $17,759.20, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, and has a completion date of March 4, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition....